David Ferrick has been named vice president of biology and clinical applications at Guava Technologies, the company said on July 6.
Ferrick was previously CEO and director of Sarges Discovery, a Davis, Calif.-based oncogenome research and cancer drug discovery company that Ferrick co-founded in 1999, Guava said. Prior to this, he served as director of molecular and cellular biology at Rigel Pharmaceuticals.
Ferrick also has held numerous academic positions, including associate professor in the department of pathology, microbiology, and immunology at the University of California, Davis. He has also worked at the Ontario Cancer Research Center and the Walter Reed Army Institute. He holds a PhD in immunology from Georgetown University.